Cargando…

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19

BACKGROUND: There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) during the coronavirus disease 2019 (COVID-19) pandemic. This study sought to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Si-Hyuck, Lee, Dong-Hoon, Han, Kyung-Do, Jung, Jin-Hyung, Park, Sang-Hyun, Dai, Andrew M., Wei, Henry G., Yoon, Chang-Hwan, Youn, Tae-Jin, Chae, In-Ho, Kim, Cheol-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166420/ https://www.ncbi.nlm.nih.gov/pubmed/34059140 http://dx.doi.org/10.1186/s40885-021-00168-0

Ejemplares similares

Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension
por: Moon, Ju-Young
Publicado: (2013)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Renin-Angiotensin Aldosterone System and Hypertension: Current Approaches and Future Directions
por: Flack, John M., et al.
Publicado: (2007)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Andersen, Karl
Publicado: (2009)

The role of renin-angiotensin aldosterone system related micro-ribonucleic acids in hypertension
por: Wang, Hui-Bo, et al.
Publicado: (2015)

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2022)

Activation of the Renin–Angiotensin–Aldosterone System Is Attenuated in Hypertensive Compared with Normotensive Pregnancy
por: Shoemaker, Robin, et al.
Publicado: (2023)

Prognosis after discontinuing renin angiotensin aldosterone system inhibitor for heart failure with restored ejection fraction after acute myocardial infarction
por: Lee, Seung Hun, et al.
Publicado: (2023)

The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment
por: Lumbers, Eugenie R., et al.
Publicado: (2022)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System
por: Maris, Stephen A, et al.
Publicado: (2019)

Erratum for The renin‐angiotensin‐aldosterone system and its suppression
Publicado: (2019)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension?
por: Hahntow, Ines N, et al.
Publicado: (2010)

Targeting the Renin–Angiotensin–Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Regulation of human salt-sensitivite hypertension by myeloid cell renin-angiotensin-aldosterone system
por: Ertuglu, Lale A., et al.
Publicado: (2023)

Association between Polymorphisms in the Renin-Angiotensin-Aldosterone System Genes and Essential Hypertension in the Han Chinese Population
por: Ji, Lindan, et al.
Publicado: (2013)

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension
por: Zeng, Weiwei, et al.
Publicado: (2022)

Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system
por: Jin, Ze-Ning, et al.
Publicado: (2016)

Contribution of Four Polymorphisms in Renin-Angiotensin-Aldosterone-Related Genes to Hypertension in a Thai Population
por: Charoen, Pimphen, et al.
Publicado: (2019)

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
por: Golpe, Rafael, et al.
Publicado: (2020)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
por: Xu, Wei, et al.
Publicado: (2022)

Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
por: Golpe, Rafael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rjbd1sns9th034f0rcjvm72v6f